衰弱、体成分与新发血液透析患者死亡风险:PACE研究
本研究纳入370例新发血液透析患者,采用Fried表型评估衰弱,分析衰弱与全身性肥胖(BMI≥30 kg/m²)、腹型肥胖(腰臀比≥中位数)和死亡风险的关联。结果显示衰弱与死亡风险增加相关(HR 1.66,95%CI 1.03-2.67),且衰弱合并全身性肥胖(HR 3.77)或腹型肥胖(HR 2.38)的患者死亡风险更高;无肥胖的衰弱患者未见死亡风险增加。
要点
- 新发血液透析患者中衰弱常见(52%),且与死亡风险增加独立相关。
- 衰弱合并全身性肥胖或腹型肥胖的患者死亡风险显著升高,衰弱不合并肥胖者风险未增加。
- BMI与死亡风险呈负相关,但衰弱合并肥胖者仍为高风险人群,需加强风险分层。
核心结论
- 在新发血液透析成人中,衰弱与死亡风险增加相关,即使在肥胖患者中也是如此。
- 衰弱合并肥胖的血液透析患者可能是一个常被忽视的高风险人群,因为肥胖通常被认为具有保护作用。
- 测量衰弱和肥胖可能有助于风险分层。
研究设计与样本
- 研究纳入370例新发血液透析患者,来自PACE(Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease)研究。
- 采用Fried表型评估衰弱,全身性肥胖定义为BMI≥30 kg/m²,腹型肥胖定义为腰臀比≥中位数腰臀比。
- 分析衰弱、肥胖与死亡风险的关联。
主要发现
- 患者平均年龄55岁,42%为女性,73%为非裔美国人,57%患糖尿病,52%存在衰弱。
- 衰弱患者平均BMI较高(衰弱组30.3 kg/m²,非衰弱组28.3 kg/m²;P=0.02),腰臀比相似(P=0.8)。
- 衰弱与死亡风险增加1.66倍相关(95%CI 1.03-2.67)。
- BMI与死亡风险降低相关:25.0-29.9 kg/m²组HR 0.53(95%CI 0.31-0.93);≥30 kg/m²组HR 0.34(95%CI 0.19-0.62)。
关键数值与推荐
- 衰弱评估采用Fried表型。
- 全身性肥胖定义为BMI≥30 kg/m²。
- 腹型肥胖定义为腰臀比≥中位数腰臀比。
临床怎么用
- 对新发血液透析患者应评估衰弱状态,尤其关注衰弱合并肥胖的患者,因其死亡风险显著升高。
- 不应仅因肥胖而认为患者风险较低,需结合衰弱评估进行综合风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Frail obese community-dwelling older adults are at increased mortality risk. Among hemodialysis (HD) patients, frailty is common and associated with increased mortality risk; however, in dialysis, obesity is associated with decreased mortality risk. Whether the frail-obese phenotype is associated with increased mortality risk among HD patients remains unclear. METHODS: This study included 370 incident HD patients enrolled in the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study. We measured frailty using the Fried phenotype, general obesity [body mass index (BMI) ≥30 kg/m2] and abdominal obesity [waist:hip ratio (WHR) ≥median WHR] and estimated their associations with mortality. RESULTS: The mean age was 55 years, with 42% female, 73% African American, 57% diabetic and 52% frail. Frail HD patients had higher mean BMI (frail = 30.3 kg/m2, non-frail = 28.3 kg/m2; P = 0.02) and similar WHR (P = 0.8). Twenty-two percent were frail with general obesity and 27% were frail with abdominal obesity. Frailty was associated with 1.66-fold increased mortality risk [95% confidence interval (CI) 1.03-2.67]. BMI was associated with a decreased mortality risk [25.0-29.9 kg/m2 hazard ratio (HR) 0.53 (95% CI 0.31-0.93); ≥30 kg/m2 HR 0.34 (95% CI 0.19-0.62)]. Frailty was associated with elevated mortality risk among HD patients with general [HR 3.77 (95% CI 1.10-12.92)] and abdominal obesity [HR 2.38 (95% CI 1.17-4.82)]. Frailty was not associated with mortality among HD patients without general or abdominal obesity. CONCLUSIONS: In adults initiating HD, frailty was associated with elevated mortality risk, even among the obese. Frail-obese HD patients may be a high-risk, often-overlooked population, as obesity is assumed to be protective. Measurement of frailty and obesity may facilitate risk stratification.
引用
- Fitzpatrick J, Sozio SM, Jaar BG, et al. Frailty, body composition and the risk of mortality in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease study. Nephrol Dial Transplant. 2019. PMID: 29868775. doi:10.1093/ndt/gfy124
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。